Sage Journals: Discover world-class research

Abstract

Background

Malaysia is now confronting a challenge of increasing health care expenditures over the years. Due to the absence of drug price regulation in Malaysia, pharmaceutical companies, wholesaler, and health care professional can set their own retail selling price. Consequently, it has caused highly markup of pharmaceutical products by unscrupulous health care professional. The aim of this study was to test the feasibility of simulated client method in obtaining medicine price, to access the actual selling price of selected medicines, to evaluate the medicine price variation according to different districts and types of pharmacies, and to identify the percentage of profit margin of selected medicines.

Method

Simulated client method was adopted in this study by using cluster random sampling technique. The selected 85 community pharmacies all were from state of Penang. Ten people of Universiti Sains Malaysia undergraduate students had been recruited as simulated clients to elicit information about pharmaceutical prices variation for the top 5 most common Group B Innovator Brand, five Group B lower price generic medicines, and five types of Group C dispensing medicines which are highly used in Malaysia. The collected data were analyzed by using Statistical Package for the Social Sciences version 17.0.

Results

From the 80 pharmacies, 34 (42.5%) of them were located in Penang Island and 46 (57.5%) were located in the Penang mainland. The price of Plavix®(Clopidogrel) 75 mg was highly variable within Penang (Ringgit Malaysia 3.94 ± 0.51). The prices of Norvasc® 5 mg and Plavix® were reported significant from the selected five districts [(p = 0.001) and (p = 0.031), respectively]. The actual selling prices of the five types of innovator prescription drugs were lower than the recommended selling price by Malaysia Pharmaceutical Service Division with at least 35%.

Conclusion

The high price of medicines in Malaysia is not mainly due to markup from community pharmacies, but the high markups along the pharmaceutical supply chain.

Keywords

Drug price regulation simulated client method pharmaceutical price war

Get full access to this article

View all access options for this article.

References

Fuchs VR. The growing demand for medical care. In: Fuchs VR (ed.), The growing demand for medical care. NBER, vol. 2, 1968, pp. 1–8.

Ewen M and Dey D. Medicines: too costly and too scarce. Health Action International, http://www. haiweb. org/medicineprices (2005, accessed 24 January 2007).

Soumerai

Ross-Degnan

. Inadequate prescription-drug coverage for Medicare enrollees—a call to action. N Engl J Med 1999; 340: 722–722.

World Health Organization and Health Action International. Medicine prices—a new approach to measurement, http://whqlibdoc.who.int/hq/2003/WHO_EDM_PAR_2003.2.pdf (2003, accessed 6 June 2013).

World Health Organization. Equitable access to essential medicines: a framework for collective action, http://whqlibdoc.who.int/hq/2004/WHO_EDM_2004.4.pdf (2004, accessed 11 June 2013).

Steinman

Sands

Covinsky

. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 2001; 16: 793–799.

Goldman

Joyce

Zheng

. Prescription drug cost sharing. J Am Med Assoc 2007; 298: 61–69.

Tandon A, Murray CJ, Lauer JA, et al. Measuring overall health system performance for 191 countries, http://www.who.int/healthinfo/paper30.pdf (2000, accessed 11 June 2013).

Bahrom S. Robust growth seen for healthcare industry, https://www.freemalaysiatoday.com/category/business/2013/02/06/robust-growth-seen-for-healthcare-industry/ (2013, accessed 11 June 2013).

10.

Whynes

Sach

. Equity in health care financing: the case of Malaysia. Int J Equity Health 2008; 7: 15–15.

11.

Pharmaceutical Services Division Ministry of Health Malaysia. Ministry of Health Drug Formulary 2009. 6th ed. PetalingJaya, Selangor, Malaysia: Pharmaceutical Services Division, Ministry of Health Malaysia, 2009, p. 655.

12.

Malaysian Medical Resource. National pharmaceutical formulary 2012, http://medicine.com.my/wp/2012/09/national-pharmaceutical-formulary-2012/ (2012, accessed 26 November 2013).

13.

Director General of Health Malaysia. Essential drugs concept—an international perspective, http://www.prn.usm.my/old_website/isdb/speech.html (1997, accessed 26 November 2013).

14.

Ministry of Health Malaysia. Malaysia’s health, http://www.moh.gov.my/images/gallery/publications/mh/Malaysia%20Health%202008-2.pdf (2008, accessed 20 July 2014).

15.

Chee HL and Barraclough S (eds). Health Care in Malaysia: The Dynamics of Provision, Financing and Access. London: Routledge, 2007.

16.

Malaysian Pharmaceutical Service Division. Recommended retail price (RRP) for NEDL 2011, http://www.pharmacy.gov.my/v2/en/documents/recommended-retail-price-rrp-nedl-2011.html (2012, accessed 26 November 2013).

17.

Pharmaceutical Service Division Ministry of Health Malaysia. Malaysian national medicines policy, http://www.pharmacy.gov.my/v2/en/documents/malaysian-national-medicines-policy-dunas.html (2012, accessed 21 July 2014).

18.

Hassali

Shafie

Babar

ZUD

. A study comparing the retail drug prices between Northern Malaysia and Australia. J Pharm Health Serv Res 2012; 3(2): 103–107.

19.

Kolassa

. Prices politic, and problems—a pricing philosophy. J Pharm Mark Pract 1997; 1: 21–27.

20.

Mahmood

Bukhari

. Pharmaceutical management and marketing, Faisalabad, Pakistan: Tariq Academy, 2002, pp. 115–144.

21.

Babar ZUD, Izham MIM, Singh H, et al. A survey on medicine prices availability, affordability and price components in Malaysia using the WHO/HAI methodology, http://apps.who.int/medicinedocs/documents/s18599en/s18599en.pdf (2005, accessed 5 December 2012).

22.

Babar ZUD, Ibrahim MIM, Singh H, et al. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia. Plos Medicine 2007; 4(3); e82.

23.

Hassali

Tan

Saleem

. A qualitative exploration of perceptions toward pharmaceutical price war among community pharmacists in the state of Penang, Malaysia. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 2013; 13(1): 44–53.

24.

Hassali

Shafie

Al-Haddad

. A qualitative study exploring the impact of the pharmaceutical price war among community pharmacies in the state of Penang, Malaysia. J Clin Diag Res 2010; 4(5): 3161–3169.

25.

Hill

. Medicines prices and Malaysia—untangling the medicines web. PLoS Med 2007; 4: e149–e149.

26.

Rethans

J-J

Westin

Hays

. Methods for quality assessment in general practice. Family Pract 1996; 13: 468–476.

27.

Kinnersley

Pill

. Potential of using simulated patients to study the performance of general practitioners. Br J Gen Pract 1993; 43: 297–297.

28.

Madden

. Undercover careseekers: simulated clients in the study of health provider behavior in developing countries. Soc Sci Med 1997; 45: 1465–1482.

29.

Pharmaceutical Service Division Ministry of Health Malaysia. Private Sector Medicines Wholesale Price List 2011 – Controlled Medicines, http://www.cornerstone.my/pharmacy_intranet/aeimages//File/hargaubat/2012/Private_Sector_Cont_1.pdf (2011, accessed 10 October 2014).

30.

Trochim WMK. Research methods knowledge base, http://www.socialresearchmethods.net/kb/sampprob.php (2006, 20 November 2012).

31.

Saebu

Rethans

J-J

. Management of patients with angina pectoris by GPs: a study with standardized (simulated) patients in actual practice. Family Pract 1997; 14: 431–435.

32.

Shafie

Hassali

. Price comparison between innovator and generic medicines sold by community pharmacies in the state of Penang, Malaysia. J Gener Med: Bus J Gener Med Sect 2008; 6: 35–42.

33.

Wertheimer

Grumer

. Overview of international pharmacy pricing. Pharmacoeconomics 1992; 2: 449–455.

34.

The Economic Times. Govt to regulate rates of 652 medicines; prices set to fall, http://articles.economictimes.indiatimes.com/2013-05-17/news/39336744_1_essential-drugs-price-control-indian-pharmaceutical-alliance (2013, accessed 25 May 2013).

35.

Gellad WF, Choudhry NK, Friedberg MW, et al. Variation in drug prices at pharmacies: are prices higher in poorer areas? Health Services Res 2009; 44(2p1): 606–617.

36.

Malaysian Pharmaceutical Society. Find a pharmacy near you, http://www.mps.org.my/index.cfm?&menuid=90 (2014, accessed 1 June 2014).

37.

Besanko D, Braeutigam R, Braeutigam RR, et al. Microeconomics. 3rd ed. New Jersy, USA: John Wiley & Sons, 2010.

38.

Murugiah NS and Kumar M. Elements of marketing mix that affects brand loyalty of prescription drugs in Penang. Doctoral dissertation, USM, 2009.

39.

Malaysian Pharmaceutical Society. An “honest-voice” against unethical promotion, http://www.mps.org.my/newsmaster.cfm?&menuid=37&action=view&retrieveid=3603 (2012, 15 December, 2012).

40.

Gan BZ. Say no to inducement to medical prescribers, https://www.facebook.com/groups/147352308715470/permalink/428227587294606/ (2013, accessed 25 November 2013).

41.

Malaysian Pharmaceutical Society and Malaysian community Pharmacy Guild. Community Pharmacy Pricing Issues And Strategies, http://www.mcpg.org.my/index.php?root=MjIy&detail=OTA= (2013, accessed 19 November 2013).

42.

Kamat

Nichter

. Pharmacies, self-medication and pharmaceutical marketing in Bombay, India. Soc Sci Med 1998; 47: 779–794.

43.

Malaysia Competition Commission. Competition act 2010, http://www.mycc.gov.my/files/announcement/06c727d2-d538-43ba-99fe-40df475d0a8d.pdf (2010, accessed 20 December 2012).

44.

Ewen M and Dey D. Medicines: too costly and too scarce, www.haiweb.org/medicineprices/2005/PricingbriefingpaperFINAL.doc (2005, accessed 10 December 2012).

45.

Consumers Association of Penang. The Money Book. Penang (Malaysia): Consumer Association of Penang, High cost of medical care, 2004, pp.184–185.

46.

Covington TR. Nonprescription drug therapy: issues and opportunities. Am J Pharmaceut Educ 2006; 70: 137.

47.

Hassali MA. Affordable healthcare: prices of some drugs are not justified, http://www.mps.org.my/newsmaster.cfm?&menuid=36&action=view&retrieveid=3656 (2012, accessed 21 May 2013).

Assessment of medicines price variation among community pharmacies in the state of Penang,Malaysia by using simulated client method

Abstract

Background

Method

Results

Conclusion

Keywords

Get full access to this article

References